How strong is the preclinical evidence for E-synNotch CAR T therapy in treating solid tumors?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18408086
Cited by: 0

Abstract

The preclinical evidence for E-synNotch CAR T therapy indicates promising potential in overcoming barriers associated with solid tumors, but further validation in clinical trials is warranted.

Fields of Study & Subjects

CAR-T cell therapy research Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
29 January 2026